Form D — Altrartis Therapeutics Inc.

0001231919-26-001488 · filed Oct 22, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Other filings

Offering

Industry: Other
Exemptions: 06b
Reported offering amount: $10,999,977
Reported amount sold: $10,999,977
Minimum investment: $0
Investors: 11
Sales commission: $0
Finders' fees: $0

Issuer

Name: Altrartis Therapeutics Inc.
CIK: 2157050
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2025
Address: 228 PARK AVE S # 505778
NEW YORK, NY 10003-1502
Phone: 49 211 87973990185

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Florian Brand · Executive Officer

New York, NY Find on LinkedIn ↗
Lars Christian Wilde · Director

New York, NY Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗